Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Standard Approaches to Relapsed Indolent Non-Hodgkin's Lymphoma
Thomas E. Witzig
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Standard Approaches to Relapsed Indolent Non-Hodgkin's Lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
100%
Lymphoma
44%
Radioimmunotherapy
36%
Recurrence
30%
Rituximab
28%
Drug Therapy
23%
Follicular Lymphoma
16%
Induction Chemotherapy
15%
Lymphocyte Count
14%
Proxy
13%
Reaction Time
12%
Stem Cells
9%
Therapeutics
8%
Transplants
8%
Survival
7%
Pharmaceutical Preparations
5%
Neoplasms
4%